Giffin Daughtridge (Co-Founder/CEO of UrSure) and his team have developed a test that tells doctors whether their patients have been taking the drug PrEP, which is 99% effective at preventing HIV. Winner of the 2016 Harvard Business School New Venture Competition, Giffin is pursuing an MD/MPA with the University of Pennsylvania and the Harvard Kennedy School.